188 related articles for article (PubMed ID: 33924892)
1. Concerted Actions by PIICP, CTXII, and TNF-α in Patients with Juvenile Idiopathic Arthritis.
Winsz-Szczotka K; Kuźnik-Trocha K; Lachór-Motyka I; Lemski W; Olczyk K
Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33924892
[TBL] [Abstract][Full Text] [Related]
2. Etanercept improves lipid profile and oxidative stress measures in patients with juvenile idiopathic arthritis.
De Sanctis S; Marcovecchio ML; Gaspari S; Del Torto M; Mohn A; Chiarelli F; Breda L
J Rheumatol; 2013 Jun; 40(6):943-8. PubMed ID: 23547210
[TBL] [Abstract][Full Text] [Related]
3. High adiposity and serum leptin accompanied by altered bone turnover markers in severe juvenile idiopathic arthritis.
Markula-Patjas KP; Ivaska KK; Pekkinen M; Andersson S; Moilanen E; Viljakainen HT; Mäkitie O
J Rheumatol; 2014 Dec; 41(12):2474-81. PubMed ID: 25320222
[TBL] [Abstract][Full Text] [Related]
4. Association of neopterin as a marker of immune system activation and juvenile rheumatoid arthritis activity.
Shady MM; Fathy HA; Ali A; Youness ER; Fathy GA
J Pediatr (Rio J); 2015; 91(4):352-7. PubMed ID: 25727025
[TBL] [Abstract][Full Text] [Related]
5. Effects of Etanercept and Adalimumab on Serum Levels of Cartilage Remodeling Markers in Women with Rheumatoid Arthritis.
Szeremeta A; Jura-Półtorak A; Zoń-Giebel A; Olczyk K; Komosińska-Vassev K
J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629227
[TBL] [Abstract][Full Text] [Related]
6. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
[TBL] [Abstract][Full Text] [Related]
7. Effects of etanercept on serum biochemical markers of cartilage metabolism in patients with spondyloarthropathy.
Briot K; Roux C; Gossec L; Charni N; Kolta S; Dougados M; Garnero P
J Rheumatol; 2008 Feb; 35(2):310-4. PubMed ID: 18203315
[TBL] [Abstract][Full Text] [Related]
8. Association between serum inflammatory cytokines and disease activity in juvenile idiopathic arthritis.
Ou LS; See LC; Wu CJ; Kao CC; Lin YL; Huang JL
Clin Rheumatol; 2002 Feb; 21(1):52-6. PubMed ID: 11954886
[TBL] [Abstract][Full Text] [Related]
9. Juvenile idiopathic arthritis patients have a distinct cartilage and bone biomarker profile that differs from healthy and knee-injured children.
Struglics A; Saleh R; Sundberg E; Olsson M; Erlandsson Harris H; Aulin C
Clin Exp Rheumatol; 2020; 38(2):355-365. PubMed ID: 31694747
[TBL] [Abstract][Full Text] [Related]
10. Periarticular bone gain at proximal interphalangeal joints and changes in bone turnover markers in response to tumor necrosis factor inhibitors in rheumatoid and psoriatic arthritis.
Szentpetery A; McKenna MJ; Murray BF; Ng CT; Brady JJ; Morrin M; Radovits B; Veale DJ; Fitzgerald O
J Rheumatol; 2013 May; 40(5):653-62. PubMed ID: 23457381
[TBL] [Abstract][Full Text] [Related]
11. Tocilizumab treatment in juvenile idiopathic arthritis patients: A single center experience.
Demir S; Sönmez HE; Arslanoğlu-Aydın E; Özen S; Bilginer Y
Turk J Pediatr; 2019; 61(2):180-185. PubMed ID: 31951328
[TBL] [Abstract][Full Text] [Related]
12. Trajectories of disease courses in the inception cohort of newly diagnosed patients with JIA (ICON-JIA): the potential of serum biomarkers at baseline.
Ganeva M; Fuehner S; Kessel C; Klotsche J; Niewerth M; Minden K; Foell D; Hinze CH; Wittkowski H
Pediatr Rheumatol Online J; 2021 May; 19(1):64. PubMed ID: 33933108
[TBL] [Abstract][Full Text] [Related]
13. Fibulin-3 and other cartilage metabolism biomarkers in relationship to calprotectin (MRP8/14) and disease activity in rheumatoid arthritis patients treated with anti-TNF therapy.
Kopec-Medrek M; Kucharz EJ
Adv Clin Exp Med; 2018 Mar; 27(3):383-389. PubMed ID: 29533545
[TBL] [Abstract][Full Text] [Related]
14. The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus.
Bobek D; Grčević D; Kovačić N; Lukić IK; Jelušić M
Pediatr Rheumatol Online J; 2014; 12():50. PubMed ID: 25516724
[TBL] [Abstract][Full Text] [Related]
15. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.
Garnero P; Piperno M; Gineyts E; Christgau S; Delmas PD; Vignon E
Ann Rheum Dis; 2001 Jun; 60(6):619-26. PubMed ID: 11350852
[TBL] [Abstract][Full Text] [Related]
16. 90K immunostimulatory glycoprotein in children with juvenile idiopathic arthritis.
Cecamore C; Marsili M; Salvatore R; Troiani R; D'Egidio M; Tinari N; Pelliccia P; Chiarelli F; Marcovecchio ML; Breda L
Mod Rheumatol; 2018 Jul; 28(4):637-641. PubMed ID: 29157059
[TBL] [Abstract][Full Text] [Related]
17. Bone alkaline phosphatase and collagen markers as early predictors of height velocity response to growth-promoting treatments in short normal children.
Crofton PM; Stirling HF; Schönau E; Kelnar CJ
Clin Endocrinol (Oxf); 1996 Apr; 44(4):385-94. PubMed ID: 8706304
[TBL] [Abstract][Full Text] [Related]
18. Serum amyloid A circulating levels and disease activity in patients with juvenile idiopathic arthritis.
Cantarini L; Giani T; Fioravanti A; Iacoponi F; Simonini G; Pagnini I; Spreafico A; Chellini F; Galeazzi M; Cimaz R
Yonsei Med J; 2012 Sep; 53(5):1045-8. PubMed ID: 22869491
[TBL] [Abstract][Full Text] [Related]
19. Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritis.
Tynjälä P; Lahdenne P; Vähäsalo P; Kautiainen H; Honkanen V
Ann Rheum Dis; 2006 Aug; 65(8):1044-9. PubMed ID: 16449314
[TBL] [Abstract][Full Text] [Related]
20. Relation of interleukin-6, TNF-alpha and interleukin-1alpha with disease activity and severity in juvenile idiopathic arthritis patients.
Spîrchez M; Samaşca G; Iancu M; Bolba C; Miu N
Clin Lab; 2012; 58(3-4):253-60. PubMed ID: 22582498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
